Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of <i>HLA-B*15:02</i> Genotyping as Standard-of-Care.

Sung, Cynthia; Tan, Liesbet; Limenta, Michael; Ganesan, Ganga; Toh, Dorothy; Chan, Cheng Leng

Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care.

Sung, Cynthia; Tan, Liesbet; Limenta, Michael; Ganesan, Ganga; Toh, Dorothy; Chan, Cheng Leng.

Affiliation

Sung C; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore.
Tan L; Health Services & Systems Research Programme, Duke-NUS Medical School, Singapore, Singapore.
Limenta M; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore.
Ganesan G; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore.
Toh D; Policy Research and Evaluation Division, Ministry of Health, Singapore, Singapore.
Chan CL; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Singapore, Singapore.

Front Pharmacol ; 11: 527, 2020.

Article in En | MEDLINE | ID: mdl-32457602

Key words

HLA-B*15:02; StevenJohnson syndrome; carbamazepine; levetiracetam; serious cutaneous skin reactions; toxic epidermal necrolysis (StevensJohnson syndrome/toxic epidermal necrolysis)

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Front Pharmacol Year: 2020 Type: Article Affiliation country: Singapore

Fulltext

XML

PubMed Links

Search on Google